OBJECTIVE: Genes likely play a substantial role in the etiology of attention-deficit/hyperactivity disorder (ADHD). However, the genetic architecture of the disorder is unknown, and prior genome-wide association studies (GWAS) have not identified a genome-wide significant association. We have conducted a third, independent, multisite GWAS of DSM-IV-TR ADHD. METHOD: Families were ascertained at Massachusetts General Hospital (MGH; N = 309 trios), Washington University at St. Louis (WASH-U; N = 272 trios), and University of California at Los Angeles (UCLA; N = 156 trios). Genotyping was conducted with the Illumina Human1M or Human1M-Duo BeadChip platforms. After applying quality control filters, association with ADHD was tested with 835,136 SNPs in 735 DSM-IV ADHD trios from 732 families. RESULTS: Our smallest p value (6.7E-07) did not reach the threshold for genome-wide statistical significance (5.0E-08), but one of the 20 most significant associations was located in a candidate gene of interest for ADHD (SLC9A9, rs9810857, p = 6.4E-6). We also conducted gene-based tests of candidate genes identified in the literature and found additional evidence of association with SLC9A9. CONCLUSIONS: We and our colleagues in the Psychiatric GWAS Consortium are working to pool together GWAS samples to establish the large data sets needed to follow-up on these results and to identify genes for ADHD and other disorders. 2010 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.
OBJECTIVE: Genes likely play a substantial role in the etiology of attention-deficit/hyperactivity disorder (ADHD). However, the genetic architecture of the disorder is unknown, and prior genome-wide association studies (GWAS) have not identified a genome-wide significant association. We have conducted a third, independent, multisite GWAS of DSM-IV-TR ADHD. METHOD: Families were ascertained at Massachusetts General Hospital (MGH; N = 309 trios), Washington University at St. Louis (WASH-U; N = 272 trios), and University of California at Los Angeles (UCLA; N = 156 trios). Genotyping was conducted with the Illumina Human1M or Human1M-Duo BeadChip platforms. After applying quality control filters, association with ADHD was tested with 835,136 SNPs in 735 DSM-IV ADHD trios from 732 families. RESULTS: Our smallest p value (6.7E-07) did not reach the threshold for genome-wide statistical significance (5.0E-08), but one of the 20 most significant associations was located in a candidate gene of interest for ADHD (SLC9A9, rs9810857, p = 6.4E-6). We also conducted gene-based tests of candidate genes identified in the literature and found additional evidence of association with SLC9A9. CONCLUSIONS: We and our colleagues in the Psychiatric GWAS Consortium are working to pool together GWAS samples to establish the large data sets needed to follow-up on these results and to identify genes for ADHD and other disorders. 2010 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.
Authors: D J Cutler; M E Zwick; M M Carrasquillo; C T Yohn; K P Tobin; C Kashuk; D J Mathews; N A Shah; E E Eichler; J A Warrington; A Chakravarti Journal: Genome Res Date: 2001-11 Impact factor: 9.043
Authors: Stephen V Faraone; Roy H Perlis; Alysa E Doyle; Jordan W Smoller; Jennifer J Goralnick; Meredith A Holmgren; Pamela Sklar Journal: Biol Psychiatry Date: 2005-01-21 Impact factor: 13.382
Authors: Richard D Todd; Nantawat Sitdhiraksa; Wendy Reich; Ted H C Ji; Cynthia A Joyner; Andrew C Heath; Rosalind J Neuman Journal: J Am Acad Child Adolesc Psychiatry Date: 2002-07 Impact factor: 8.829
Authors: M G de Silva; K Elliott; H-H Dahl; E Fitzpatrick; S Wilcox; M Delatycki; R Williamson; D Efron; M Lynch; S Forrest Journal: J Med Genet Date: 2003-10 Impact factor: 6.318
Authors: Richard D Todd; Cynthia A Joyner; Andrew C Heath; Rosalind J Neuman; Wendy Reich Journal: J Am Acad Child Adolesc Psychiatry Date: 2003-12 Impact factor: 8.829
Authors: A S Cristino; S M Williams; Z Hawi; J-Y An; M A Bellgrove; C E Schwartz; L da F Costa; C Claudianos Journal: Mol Psychiatry Date: 2013-02-26 Impact factor: 15.992
Authors: Marieke Klein; Monique van der Voet; Benjamin Harich; Kimm J E van Hulzen; A Marten H Onnink; Martine Hoogman; Tulio Guadalupe; Marcel Zwiers; Johanne M Groothuismink; Alicia Verberkt; Bonnie Nijhof; Anna Castells-Nobau; Stephen V Faraone; Jan K Buitelaar; Annette Schenck; Alejandro Arias-Vasquez; Barbara Franke Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2015-06-10 Impact factor: 3.568
Authors: Ziarih Hawi; Natasha Matthews; Edwina Barry; Aiveen Kirley; Joseph Wagner; Robyn H Wallace; Helen S Heussler; Alasdair Vance; Michael Gill; Mark A Bellgrove Journal: Psychopharmacology (Berl) Date: 2012-09-29 Impact factor: 4.530
Authors: Crystelle A Egan; Susan E Marakovitz; Julia A O'Rourke; Lisa Osiecki; Cornelia Illmann; Lauren Barton; Elizabeth McLaughlin; Rachel Proujansky; Justin Royal; Heather Cowley; Martha Rangel-Lugo; David L Pauls; Jeremiah M Scharf; Carol A Mathews Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2012-10-22 Impact factor: 3.568
Authors: August Blackburn; Harald H H Göring; Angela Dean; Melanie A Carless; Thomas Dyer; Satish Kumar; Sharon Fowler; Joanne E Curran; Laura Almasy; Michael Mahaney; Anthony Comuzzie; Ravindranath Duggirala; John Blangero; Donna M Lehman Journal: Eur J Hum Genet Date: 2012-08-22 Impact factor: 4.246
Authors: Z Hawi; T D R Cummins; J Tong; M Arcos-Burgos; Q Zhao; N Matthews; D P Newman; B Johnson; A Vance; H S Heussler; F Levy; S Easteal; N R Wray; E Kenny; D Morris; L Kent; M Gill; M A Bellgrove Journal: Mol Psychiatry Date: 2016-07-26 Impact factor: 15.992